Skip to content

Clinical trial to evaluate the efficacy and safety of [11C]K-2 in healthy volunteers

Clinical trial to evaluate the efficacy and safety of [11C]K-2 in healthy volunteers - Clinical trial to evaluate the efficacy and safety of [11C]K-2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020975
Enrollment
8
Registered
2016-02-12
Start date
2016-02-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

single administration of [11C]K-2

Sponsors

Yokohama city university, school of medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. japanese healthy volunteer 2. male 3. age is between 20-40 4. BMI is between 18.5-25.0 5. The laboratory data in the Blood test is within normal limit 6. HBV, HCV, HIV, syphilis negative 7. The man who can agree by himself

Exclusion criteria

Exclusion criteria: 1. The man cannot agree by himself 2. The man who has past or current history of psychiatric disorder 3. current smoker or past smoker who quit smoking within 6 months 4. The man who is disclosed brain disease by MRI study 5. The man who has pacemaker or metal object inside his body 6. The man who has tatoo 7. claustrophobia 8. The man who participates in clinical trial where he underwent nuclear medicine scan within 6 months 9. The man who donates his blood 400ml within 12 weeks or 200ml within 4 weeks or more little within 2 weeks 10. The man who participates in other clinical trial within 12 weeks 11. The man who continues and cannot quit using drugs 12. The man who is judged inadequate by the research medical doctor

Design outcomes

Primary

MeasureTime frame
To measure the dinamics and distribution volumes of [11C]K-2 in the brain.

Secondary

MeasureTime frame
To study the adverse event about [11C]K-2 during post 4-10 days after administration of it.

Countries

Japan

Contacts

Public Contactakane sano

Yokohama city university, school of medicine physiology

akane@med.yokohama-cu.ac.jp045-787-2579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026